{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:22:51Z","timestamp":1791868971091,"version":"4.3.4"},"reference-count":12,"publisher":"Akademiai Kiado Zrt.","issue":"1","license":[{"start":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T00:00:00Z","timestamp":1449878400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["J Behav Addict"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:sec sec-type=\"background\">\n          <jats:title>Background<\/jats:title>\n          <jats:p>The development of behavioral addictions (BAs) in association with dopamine agonists (DAs, commonly used to treat Parkinson\u2019s disease) has been reported. A recent report presented data that these associations are evident in the US Food and Drug Administration\u2019s (FDA) Adverse Event Reporting System (FAERS), a database containing information on adverse drug event and medication error reports submitted to the FDA. However, given that vulnerability to publicity-stimulated reporting is a potential limitation of spontaneous reporting systems like the FAERS, the potential impact of publicity on reporting in this case remains unclear.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec sec-type=\"method and aims\">\n          <jats:title>Method and aims<\/jats:title>\n          <jats:p>To investigate the potential impact of publicity on FAERS reporting of BAs in association with DAs (BAs w\/DAs) as presented by Moore, Glenmullen, and Mattison (2014), news stories covering a BA\/DA association were identified and compared with BA w\/DA and other reporting data in the FAERS.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec sec-type=\"results\">\n          <jats:title>Results<\/jats:title>\n          <jats:p>Fluctuations in the growth of BA w\/DA reporting to the FAERS between 2003 and 2012 appear to coincide with multiple periods of intensive media coverage of a BA\/DA association, a pattern that is not evident in other reporting data in the FAERS.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec sec-type=\"conclusions\">\n          <jats:title>Discussion\/Conclusions<\/jats:title>\n          <jats:p>Publicity may stimulate reporting of adverse events and premature dismissal of the potential influence of publicity on reporting may lead to mistaking an increased risk of an adverse event being reported for an increased risk of an adverse event occurring.<\/jats:p>\n        <\/jats:sec>","DOI":"10.1556\/2006.5.2016.001","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T15:01:11Z","timestamp":1450710071000},"page":"140-143","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":11,"title":["Publicity and reports of behavioral addictions associated with dopamine agonists"],"prefix":"10.1556","volume":"5","author":[{"given":"Katherine E.","family":"Gendreau","sequence":"first","affiliation":[{"name":"Independent Consultant, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N.","family":"Potenza","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry, Neurobiology and Child Study Center, Senior Scientist, CASAColumbia, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"issue":"6","key":"B1","series-title":"Pharmacoepidemiology and Drug Safety,","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/pds.1742","article-title":"Quantitative signal detection using spontaneous ADR reporting","volume":"18","author":"Bate, A.","year":"2009","unstructured":"Bate, A.\n            , & \n            \n              Evans, S.\u00a0J.\u00a0W.\n           (2009). Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiology and Drug Safety,18(6), 427\u2013436.10.1002\/pds.1742"},{"issue":"4","key":"B2","series-title":"Mayo Clinic Proceedings,","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S0025-6196(11)60538-7","article-title":"Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease","volume":"84","author":"Bostwick, J.\u00a0M.","year":"2009","unstructured":"Bostwick, J.\u00a0M.\n            , \n            \n              Hecksel, K.\u00a0A.\n            , \n            \n              Stevens, S.\u00a0R.\n            , \n            \n              Bower, J.\u00a0H.\n            , & \n            \n              Ahlskog, J.\u00a0E.\n           (2009). Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clinic Proceedings,84(4), 310\u2013316.10.1016\/S0025-6196(11)60538-7"},{"issue":"9","key":"B3","series-title":"Archives of Neurology,","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease","volume":"62","author":"Dodd, M.\u00a0L.","year":"2005","unstructured":"Dodd, M.\u00a0L.\n            , \n            \n              Klos, K.\u00a0J.\n            , \n            \n              Bower, J.\u00a0H.\n            , \n            \n              Geda, Y.\u00a0E.\n            , \n            \n              Josephs, K.\u00a0A.\n            , & \n            \n              Ahlskog, J.\u00a0E.\n           (2005). Pathological gambling caused by drugs used to treat Parkinson disease. Archives of Neurology,62(9), 1377.10.1001\/archneur.62.9.noc50009"},{"issue":"3","key":"B4","series-title":"Neurology,","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1212\/01.WNL.0000076478.45005.EC","article-title":"Pathological gambling associated with dopamine agonist therapy in Parkinson\u2019s disease","volume":"61","author":"Driver-Dunckley, E.","year":"2003","unstructured":"Driver-Dunckley, E.\n            , \n            \n              Samanta, J.\n            , & \n            \n              Stacy, M.\n           (2003). Pathological gambling associated with dopamine agonist therapy in Parkinson\u2019s disease. Neurology,61(3), 422\u2013423.10.1212\/01.WNL.0000076478.45005.EC"},{"key":"B5","author":"Edwards, J.","year":"2010","unstructured":"Edwards, J.\n           (June 7, 2010). Sex, shopping addiction lawsuits may force faster drug-safety updates. CBS News. Retrieved from http:\/\/www.cbsnews.com\/news\/sex-shopping-addiction-lawsuits-may-force-faster-drug-safety-updates\/"},{"issue":"1","key":"B6","series-title":"Journal of Behavioral Addictions,","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1556\/JBA.3.2014.1.3","article-title":"Detecting associations between behavioral addictions and dopamine agonists in the Food & Drug Administration\u2019s Adverse Event database","volume":"3","author":"Gendreau, K.\u00a0E.","year":"2014","unstructured":"Gendreau, K.\u00a0E.\n            , & \n            \n              Potenza, M.\u00a0N.\n           (2014). Detecting associations between behavioral addictions and dopamine agonists in the Food & Drug Administration\u2019s Adverse Event database. Journal of Behavioral Addictions,3(1), 21\u201326.10.1556\/JBA.3.2014.1.3"},{"issue":"4","key":"B7","series-title":"Pharmacoepidemiology and Drug Safety,","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/pds.848","article-title":"Biases affecting the proportional reporting ratio (PRR) in spontaneous reports pharmacovigilance databases: The example of sertindole","volume":"12","author":"Moore, N.","year":"2003","unstructured":"Moore, N.\n            , \n            \n              Hall, G.\n            , \n            \n              Sturkenboom, M.\n            , \n            \n              Mann, R.\n            , \n            \n              Lagnaoui, R.\n            , & \n            \n              Begaud, B.\n           (2003). Biases affecting the proportional reporting ratio (PRR) in spontaneous reports pharmacovigilance databases: The example of sertindole. Pharmacoepidemiology and Drug Safety,12(4), 271\u2013281.10.1002\/pds.848"},{"issue":"12","key":"B8","series-title":"JAMA Internal Medicine,","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore, T.\u00a0J.","year":"2014","unstructured":"Moore, T.\u00a0J.\n            , \n            \n              Glenmullen, J.\n            , & \n            \n              Mattison, D.\u00a0R.\n           (2014). Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Internal Medicine,174(12), 1930\u20131933. doi: 10.1001\/jamainternmed.2014.526210.1001\/jamainternmed.2014.5262"},{"key":"B9","author":"O\u2019Neil, J.","year":"2003","unstructured":"O\u2019Neil, J.\n           (August 12, 2003). Gambling and Parkinson\u2019s drug. The New York Times. Retrieved from http:\/\/www.nytimes.com\/2003\/08\/12\/health\/vital-signs-risks-and-remedies-gambling-and-parkinson-s-drug.html"},{"issue":"2","key":"B10","series-title":"Archives of Neurology,","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/archneur.63.2.299-b","article-title":"Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database","volume":"63","author":"Szarfman, A.","year":"2006","unstructured":"Szarfman, A.\n            , \n            \n              Doraiswamy, P.\u00a0M.\n            , \n            \n              Tonning, J.\u00a0M.\n            , & \n            \n              Levine, J.\u00a0G.\n           (2006). Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database. Archives of Neurology,63(2), 299.10.1001\/archneur.63.2.299-b"},{"issue":"2","key":"B11","series-title":"Archives of Neurology,","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1001\/archneur.64.2.212","article-title":"Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease","volume":"64","author":"Voon, V.","year":"2007","unstructured":"Voon, V.\n            , \n            \n              Thomsen, T.\n            , \n            \n              Miyasaki, J.\u00a0M.\n            , \n            \n              de Souza, M.\n            , \n            \n              Shafro, A.\n            , \n            \n              Fox, S.\u00a0H.\n            , \n            \n              Duff-Canning, S.\n            , \n            \n              Lang, A.\u00a0E.\n            , & \n            \n              Zurowski, M.\n           (2007). Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Archives of Neurology,64(2), 212\u2013216.10.1001\/archneur.64.2.212"},{"issue":"5","key":"B12","series-title":"Archives of Neurology,","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients","volume":"67","author":"Weintraub, D.","year":"2010","unstructured":"Weintraub, D.\n            , \n            \n              Koester, J.\n            , \n            \n              Potenza, M.\u00a0N.\n            , \n            \n              Siderowf, A.\u00a0D.\n            , \n            \n              Stacy, M.\n            , \n            \n              Voon, V.\n            , \n            \n              Whetteckey, J.\n            , \n            \n              Wunderlich, G.\u00a0R.\n            , & \n            \n              Lang, A.\u00a0E.\n           (2010). Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Archives of Neurology,67(5), 589.10.1001\/archneurol.2010.65"}],"container-title":["Journal of Behavioral Addictions"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/2006\/5\/1\/article-p140.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/2006\/5\/1\/article-p140.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/2006\/5\/1\/article-p140.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T16:43:31Z","timestamp":1704300211000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/2006\/5\/1\/article-p140.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,12]]},"references-count":12,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1556\/2006.5.2016.001","relation":{},"ISSN":["2062-5871","2063-5303"],"issn-type":[{"value":"2062-5871","type":"print"},{"value":"2063-5303","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,12]]}}}